Pilot Study of Intravenous Immunoglobulin in HIV-Associated Myelopathy
- 1 February 2009
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Patient Care and STDs
- Vol. 23 (2), 75-78
- https://doi.org/10.1089/apc.2008.0018
Abstract
There is no effective treatment for HIV-associated myelopathy (HIVM). The introduction of highly active antiretroviral therapy (HAART) has made little difference to its natural history. Spinal cord pathology reveals vacuolization and inflammation. Intravenous immunoglobulin (IVIg) is used successfully in a number of inflammatory conditions associated with HIV. In view of the potential for reversibility of the inflammatory response in HIVM, we treated 17 patients with IVIg twice over a 56-day study period. There was improvement in composite Medical Research Council (MRC) strength scores 28 days following the first infusion (increase in score: 3.94; p = 0.021). The second infusion did not produce further improvement, however there was little reduction from peak strength. These pilot data suggest that further investigation of the use of IVIg in HIVM is warranted.Keywords
This publication has 14 references indexed in Scilit:
- Treatment of AIDS-associated myelopathy with l -methionineNeurology, 2004
- Vacuolar Myelopathy and Vacuolar Cerebellar Leukoencephalopathy: A Late Complication of AIDS After Highly Active Antiretroviral Therapy-Induced Immune ReconstitutionAIDS Patient Care and STDs, 2002
- AIDS-associated vacuolar myelopathy A morphometric studyBrain, 1995
- Clinicopathologic correlations of HIV‐1‐associated vacuolar myelopathyNeurology, 1994
- Memory in a case of bilateral thalamic infarctionNeurology, 1992
- Treatment of HTLV-I-associated myelopathy with high-dose intravenous gammaglobulinZeitschrift für Neurologie, 1991
- Vacuolar Myelopathy in AIDSPathology - Research and Practice, 1990
- Myelopathies and retroviral infectionsAnnals of Neurology, 1987
- Vacuolar Myelopathy Pathologically Resembling Subacute Combined Degeneration in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1985